Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-11-17
1999-12-07
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514398, 514 94, 514 89, 546 22, 5462744, 548112, 5483137, 5483147, 5483195, A01N 4340, A01N 5716, C07F 932, C07D23340
Patent
active
059984473
ABSTRACT:
Compounds of the formula I ##STR1## in which B, D, E, R, W, Y, Z, b, c, d, e, f, g and have the meanings indicated in the claims, are inhibitors of the adhesion and migration of leucocytes and/or antagonists of the adhesion receptor VLA-4 which belongs to the group of integrins. The invention relates to the use of compounds of the formula I, and of pharmaceutical preparations which contain such compounds, for the treatment and prophylaxis of diseases which are caused by an un desired extent of leucocyte adhesion and/or leucocyte migration or which are associated therewith or in which cell--cell or cell-matrix interactions play a part which are based on interactions of VLA-4 receptors with their ligands, for example of inflammatory processes, rheumatoid arthritis or allergic disorders, and it also relates to the use of compounds of the formula I for the production of pharmaceuticals for use in such diseases. It further relates to novel compounds of the formula I.
REFERENCES:
patent: 5424293 (1995-06-01), Zoller et al.
Mariano J. Elices, et al., "VCAM-1 on Activated Endothelium Interacts with the Leukocyte Integrin VLA-4 at a Site Distinct from the VLA-4/Fibronectin Binding Site", Cell, vol. 60, pp. 577-584, Feb. 1990.
G. Kilger, et al., "Molecular anaylsis of the physiological and pathophysiological role of .alpha..sub.4 -integrins", J. Mol. Med: Review, vol. 73, pp. 347-354, 1995.
Thomas B. Issekutz, et al., "Rat Blood Neutrophils Express Very Late Antigen 4 and it Mediates Migration to Arthritic Joint and Dermal Inflammation", J. Exp. Med., vol. 183, pp. 2175-2184, May 1996.
Bruce N. Cronstein, et al., "The Adhesion Molecules of Inflammation", Arthritis and Rheumatism, vol. 36, No. 2, pp. 147-157, Feb. 1993.
Huels Christoph
Seiffge Dirk
Stilz Hans Ulrich
Wehner Volkmar
Hoechst Aktiengesellschaft AG
Keating Dominic
Richter Johann
LandOfFree
Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824345